These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 27283220)
1. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement. Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Gao Y; Li Z; Sun M; Li H; Guo C; Cui J; Li A; Cao F; Xi Y; Lou H; Zhai G Drug Dev Ind Pharm; 2010 Oct; 36(10):1225-34. PubMed ID: 20545506 [TBL] [Abstract][Full Text] [Related]
3. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation. Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567 [TBL] [Abstract][Full Text] [Related]
4. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation. Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of intravenously injectable curcumin nanosuspension. Gao Y; Li Z; Sun M; Guo C; Yu A; Xi Y; Cui J; Lou H; Zhai G Drug Deliv; 2011 Feb; 18(2):131-42. PubMed ID: 20939679 [TBL] [Abstract][Full Text] [Related]
6. Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis. Jiang L; Wang J; Jiang J; Zhang C; Zhao M; Chen Z; Wang N; Hu D; Liu X; Peng H; Lian M Eur J Pharm Biopharm; 2020 Jan; 146():101-110. PubMed ID: 31841689 [TBL] [Abstract][Full Text] [Related]
7. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
8. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process. Anwar M; Ahmad I; Warsi MH; Mohapatra S; Ahmad N; Akhter S; Ali A; Ahmad FJ Eur J Pharm Biopharm; 2015 Oct; 96():162-72. PubMed ID: 26241925 [TBL] [Abstract][Full Text] [Related]
9. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin. Song Z; Zhu W; Song J; Wei P; Yang F; Liu N; Feng R Drug Deliv; 2015 Jan; 22(1):58-68. PubMed ID: 24725028 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Zhang J; Tang Q; Xu X; Li N Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117 [TBL] [Abstract][Full Text] [Related]
11. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
12. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
13. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247 [TBL] [Abstract][Full Text] [Related]
14. Improved Oral Absorption of Poorly Soluble Curcumin via the Concomitant Use of Borneol. Gao Y; Chen G; Luan X; Zou M; Piao H; Cheng G AAPS PharmSciTech; 2019 Mar; 20(4):150. PubMed ID: 30903519 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin. Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852 [TBL] [Abstract][Full Text] [Related]
16. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Bi C; Miao XQ; Chow SF; Wu WJ; Yan R; Liao YH; Chow AH; Zheng Y Nanomedicine; 2017 Apr; 13(3):943-953. PubMed ID: 27884638 [TBL] [Abstract][Full Text] [Related]
17. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
19. Functionalization of nanodiamond with vitamin E TPGS to facilitate oral absorption of curcumin. Cheng B; Pan H; Liu D; Li D; Li J; Yu S; Tan G; Pan W Int J Pharm; 2018 Apr; 540(1-2):162-170. PubMed ID: 29452153 [TBL] [Abstract][Full Text] [Related]
20. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]